Taf15 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Taf15 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TAF15 (TATA-Binding Protein Associated Factor 15) is an RNA-binding protein and transcription factor belonging to the FET (FUS, EWSR1, TAF15) family. It is implicated in ALS and FTD pathogenesis. [@ratti2020]
Overview
Structure
TAF15 has a modular structure:
N-terminal Transactivation Domain: Low-complexity, QGSY-rich region
RGG Domains: Arginine-glycine-glycine repeats, involved in RNA binding
RRM Domain: RNA recognition motif for RNA binding
Zinc Finger: C-terminal zinc finger for nucleic acid binding
The low-complexity N-terminal domain is prion-like and capable of liquid-liquid phase separation.
Normal Function
Transcription
Component of TFIID transcription complex
Activates transcription from various promoters
Interactions with RNA polymerase II
RNA Processing
Alternative splicing regulation
mRNA transport in [neurons](/entities/neurons)
Stress granule formation under cellular stress
Stress Response
Localizes to stress granules during stress
Regulates translation of stress-response genes
Involved in the integrated stress response
Role in Disease
ALS (Amyotrophic Lateral Sclerosis)
Rare mutations cause familial ALS
Forms cytoplasmic inclusions in ALS motor neurons
Co-aggregates with FUS and [TDP-43](/proteins/tdp-43)
RRM domain mutations affect RNA binding
Loss-of-function may contribute to RNA metabolism defects
FTD (Frontotemporal Dementia)
TAF15 inclusions in FTD brain tissue
Part of the FUS pathology subtype
Dysregulated RNA granule dynamics
Cancer
Originally identified as oncogene (NOCA1)
TAF15-NUTM fusion in sarcomas
Therapeutic Targeting
No direct therapeutic targeting yet. Strategies under investigation:
ASOs: Antisense oligonucleotides to reduce mutant TAF15
Phase Separation Modulators: Small molecules affecting liquid-liquid phase separation
Phase separation in ALS - Cell. 2020;173(3):576-589.
Background
The study of Taf15 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
TAF15 (TATA-Binding Protein Associated Factor 15, also known as TAFII68) is an RNA-binding protein belonging to the FET (FUS, EWSR1, TAF15) family of nuclear proteins[@neumann2016]. It functions in both transcription regulation and RNA processing.
Structure
TAF15 contains:
N-terminal prion-like domain: enables aggregation
RNA recognition motif (RRM): binds RNA
C-terminal zinc finger: protein interactions
Cellular Functions
TAF15 is involved in:
Transcription initiation (as part of TFIID)
RNA splicing
RNA transport
Stress granule formation[@ratti2020]
Role in Neurodegeneration
Amyotrophic Lateral Sclerosis (ALS)
TAF15 is implicated in ALS pathogenesis through mechanisms similar to FUS- RNA granule dysfunction: stress granule accumulation
Protein aggregation: formation of insoluble inclusions
Nuclear transport defects: impaired nucleocytoplasmic transport
Frontotemporal Dementia (FTD)
In FTD, TAF15 pathology includes:
Co-aggregation with TDP-43
Formation of cytoplasmic inclusions
Dysregulation of RNA metabolism
Alzheimer's and Parkinson's Disease
While primarily associated with ALS/FTD, TAF15 may contribute to AD/PD through: